Sign in
Not yet taking people in United StatesNo phase

Medication support after hospital discharge for high-risk adults with type 2 diabetes

Tests nurse and health worker support for managing diabetes medicines after hospital discharge.

Key facts

Who runs it
University of Alabama at Birmingham
Where
Birmingham, United StatesSee the 2 sites
Trial code
Registry title
MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients
Status
Not yet recruiting
People taking part
45 people, planned
Starts
1 May 2029
Expected to end
30 Apr 2031
Type of study
Interventional
Treatments tested
  • MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention
Record updated
20 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes who left UAB Hospital and are at high risk of problems after discharge. They get 3 months of nurse and community health worker support.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Type 2 diabetes (HbA1c of 6.5% (48 mmol/mol) or higher, or related diagnosis codes). Rated high risk by the MEDBRIDGE tool for higher HbA1c, diabetes-related emergency visits or hospital stays within 3 months after discharge.
Earlier treatment
Must have been discharged from UAB Hospital or its emergency departments. Cannot be in another post-discharge study.
Biomarker or test result
HbA1c of 6.5% (48 mmol/mol) or higher, or related diagnosis codes (E11, E13, E14, R73, L97.509, K31.84).

Main reasons for not taking part

  • Under age 18
  • No sign of type 2 diabetes
  • Primary care not at Cooper Green Mercy Health Services or UAB Post Discharge Clinic
  • Unable to give informed consent
  • Already in another post-discharge intervention study

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adults aged 18 years or older
  • Diagnosis of type 2 diabetes (HbA1c of 6.5% or higher or relevant ICD-10 codes including E11, E13, E14, R73, L97.509, K31.84)
  • Discharged from UAB Hospital or its emergency departments
  • Receiving primary care at Cooper Green Mercy Health Services or UAB Post Discharge Clinic
  • Identified as high risk by the MEDBRIDGE prediction tool based on elevated risk of HbA1c elevation, diabetes-related emergency department visits, or diabetes-related hospitalizations within 3 months post-discharge

Who cannot take part

  • No indication of type 2 diabetes
  • Under age 18
  • Not affiliated with Cooper Green Mercy Health Services or UAB Post Discharge Clinic for primary care
  • Unable to provide informed consent
  • Currently enrolled in another post-discharge intervention study

Where in United States

  • Cooper Green Mercy Health ServicesBirmingham, United StatesContact: Seung-Yup Lee, PhDNot yet recruiting
  • University of Alabama at BirminghamBirmingham, United StatesContact: Seung-Yup Lee, PhDNot yet recruiting

About the trial

What the trial wants to find out

This study tests whether a support program led by a nurse case manager and community health worker can help patients with type 2 diabetes manage their medications after leaving the hospital. Many patients with diabetes take multiple medications, and changes to these medications during hospital stays can cause confusion and lead to missed doses or incorrect use. This is especially common in communities with limited access to healthcare.

Read full original descriptionShow less

The study uses a computer-based tool called MEDBRIDGE (MEDication BRIDGE) to identify patients who may be at higher risk for problems after discharge, such as worsening blood sugar control or return visits to the emergency department. Patients identified as high-risk will receive 3 months of support from a nurse case manager and community health worker team, who will help with medication questions, coordinate with their doctor, and provide follow-up check-ins.

The main goal is to find out whether this type of support program is practical to deliver and acceptable to patients. The study will also track changes in blood sugar levels and emergency department visits. Forty-five patients will be enrolled over 6 months at the University of Alabama at Birmingham and Cooper Green Mercy Health Services in Jefferson County, Alabama.

The group in the trial

  • MEDBRIDGE-Guided NCM/CHW SupportTreatment being tested

    High-risk patients with type 2 diabetes identified by the MEDBRIDGE risk stratification tool receive a 3-month post-discharge support intervention delivered by a nurse case manager (NCM) and community health worker (CHW) team.

    Treatment: MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
MEDBRIDGE: AI-Driven Risk Stratification and Care Transition Intervention to Improve Diabetes Medication Management
Plain-language title
Medication support after hospital discharge for high-risk adults with type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
20 May 2026